Journal
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
Volume 21, Issue 1, Pages 64-69Publisher
WILEY
DOI: 10.1111/1756-185X.13220
Keywords
intravenous immunoglobulin; Kawasaki disease
Categories
Ask authors/readers for more resources
Intravenous immunoglobulin (IVIg) is a purified plasma product that is used for many immune-deficient conditions and autoimmune conditions. Use of IVIg for treatment for Kawasaki disease (KD) is critical for control of inflammation. The American Heart Association (AHA) recommends a single infusion of 2 g/kg preferably given during the first 10 days of illness. In this review, we have discussed the possible mechanisms of action of IVIg in KD and its clinical usage in this condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available